UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.191

Sortiert nach

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension

Pediatric pulmonology, 2019-01, Vol.54 (1), p.66-72

2019

Volltextzugriff (PDF)

Initial dual oral combination therapy in pulmonary arterial hypertension

The European respiratory journal, 2016-06, Vol.47 (6), p.1727-1736

2016

Volltextzugriff (PDF)

Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease

Heart (British Cardiac Society), 2024-03, Vol.110 (5), p.346

2024

Volltextzugriff (PDF)

Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial

The Journal of heart and lung transplantation, 2022-05, Vol.41 (5), p.563-567

2022

Volltextzugriff (PDF)

Combined pre- and post-capillary pulmonary hypertension in left heart disease

Heart failure reviews, 2023-01, Vol.28 (1), p.137-148

2023

Volltextzugriff (PDF)

Could pulmonary arterial hypertension-specific agents be an option for Takayasu's arteritis related pulmonary hypertension?

Clinical and experimental rheumatology, 2024-04, Vol.42 (4), p.940

2024

Volltextzugriff (PDF)

Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension

Cardiovascular drugs and therapy, 2024-06, Vol.38 (3), p.651-656

2024

Volltextzugriff (PDF)

Transition from Parenteral to Oral Treprostinil in Pulmonary Arterial Hypertension

The Journal of heart and lung transplantation, 2017-02, Vol.36 (2), p.193-201

2017

Volltextzugriff (PDF)

Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials

American journal of respiratory and critical care medicine, 2021-03, Vol.203 (6), p.726-736

2021

Volltextzugriff (PDF)

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

The European respiratory journal, 2015-12, Vol.46 (6), p.1711-1720

2015

Volltextzugriff (PDF)

Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era—results from a nationwide study

Clinical rheumatology, 2024-06, Vol.43 (6), p.1919-1925

2024

Volltextzugriff (PDF)

Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension

Journal of applied physiology (1985), 2016-09, Vol.121 (3), p.623-628

2016

Volltextzugriff (PDF)

Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis

European heart journal, 2024-06, Vol.45 (21), p.1937-1952

2024

Volltextzugriff (PDF)

SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension

Circulation. Heart failure, 2024-05, Vol.17 (5), p.e011227

2024

Volltextzugriff (PDF)

Genotypes and Phenotypes of Chinese Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension—A Single-Center Study

Canadian journal of cardiology, 2019-12, Vol.35 (12), p.1851-1856

2019

Volltextzugriff (PDF)

Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE

Advances in therapy, 2024-03, Vol.41 (3), p.1103-1119

2024

Volltextzugriff (PDF)

Sorafenib as a potential strategy for refractory pulmonary arterial hypertension

Pulmonary pharmacology & therapeutics, 2017-06, Vol.44, p.46-49

2017

Volltextzugriff (PDF)

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

European journal of pediatrics, 2024-05, Vol.183 (5), p.2141-2153

2024

Volltextzugriff (PDF)

Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease

International journal of cardiology, 2017-05, Vol.235, p.67-72

2017

Volltextzugriff (PDF)

Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension

International journal of environmental research and public health, 2023-03, Vol.20 (5), p.4625

2023

Volltextzugriff (PDF)

Transition from IV epoprostenol to oral treprostinil in a patient with group 1 pulmonary arterial hypertension

American journal of health-system pharmacy, 2021-12, Vol.78 (23), p.2110-2115

2021

Volltextzugriff (PDF)

Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study

Chest, 2016-03, Vol.149 (3), p.660-666

2016

Volltextzugriff (PDF)

Adverse Events in Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Arthritis & rheumatology (Hoboken, N.J.), 2015-09, Vol.67 (9), p.2457-2465

2015

Volltextzugriff (PDF)

Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective

The National medical journal of India, 2022-11, Vol.35 (6), p.338-343, Article 338

2022

Volltextzugriff (PDF)

1 – 25 von 5.191

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.713)
Mit Volltextzugriff
(4.141)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(4.938)
Science & Technology
(4.191)
Life Sciences & Biomedicine
(4.113)
Male
(3.678)
Hypertension, Pulmonary - Drug Therapy
(2.789)
Middle Aged
(2.760)
Adult
(2.383)
Aged
(1.786)
Biological And Medical Sciences
(1.637)
Medical Sciences
(1.627)
Pulmonary Hypertension
(1.526)
Cardiovascular System & Cardiology
(1.409)
Treatment Outcome
(1.312)
Cardiac & Cardiovascular Systems
(1.296)
Hypertension, Pulmonary - Physiopathology
(1.158)
Respiratory System
(1.097)
Hypertension
(1.096)
Hypertension, Pulmonary - Etiology
(954)
General & Internal Medicine
(953)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension

Initial dual oral combination therapy in pulmonary arterial hypertension

Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease

Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease

Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial

Combined pre- and post-capillary pulmonary hypertension in left heart disease

Could pulmonary arterial hypertension-specific agents be an option for Takayasu's arteritis related pulmonary hypertension?

Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension

Transition from Parenteral to Oral Treprostinil in Pulmonary Arterial Hypertension

Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era—results from a nationwide study

Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension

Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis

SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension

Genotypes and Phenotypes of Chinese Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension—A Single-Center Study

Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE

Sorafenib as a potential strategy for refractory pulmonary arterial hypertension

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease

Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension

Transition from IV epoprostenol to oral treprostinil in a patient with group 1 pulmonary arterial hypertension

Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study

Adverse Events in Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective

Aktive Filter

Suchergebnisse filtern